Pranam Chatterjee is the Africk-Lesley Distinguished Assistant Professor of Bioengineering and Computer and Information Science at the University of Pennsylvania. His Programmable Biology Group develops new discrete generative models for the de novo design of peptide and protein biologics, spanning from algorithmic theory to experimental validation in vitro, in vivo, and translation to the clinic and field. The lab specifically develops therapeutic interventions for rare neurodegenerative diseases, pediatric sarcomas, and infertility, as well as molecules for environment bioremediation. Having received his SB, SM, and PhD from MIT, Professor Chatterjee has received the Hartwell Individual Biomedical Research Award, MIRA Award, and multiple NIH and foundation grants for his work. He has also co-founded Gameto, Inc., UbiquiTx, Inc., AtomBioworks, Inc., and Recognition Bio, Inc. which translates his research into fertility-related solutions, RNA medicines, and cancer therapeutics, respectively.